Miraki Innovation

The firm writes checks from seed and start-up phases through late-stage growth and pre-IPO rounds. This lifecycle coverage — from first institutional capital to public-market crossover — is characteristic of a permanent-capital vehicle rather than a traditional fixed-life venture fund, though Miraki has not disclosed its specific fund structure.

Miraki does not publish a formal exclusion list, but its mandate is concentrated on asset-heavy, science-risk categories: artificial intelligence, robotics, life sciences, and industrial technology. Consumer internet, brand-driven commerce, and lightly regulated financial products do not fit its technical-diligence model and are generally absent from firms with this scientific-sourcing architecture.

Miraki lists co-investment among its strategies, meaning it is structurally willing to participate in syndicates led by other institutional GPs. This is common for firms that do not seek board control but want exposure to a specific technology vertical or founding team. The terms and typical check sizes for such co-investments have not been publicly disclosed.